Press Releases

BIO’s Tom DiLenge, President of Advocacy, Law & Public Policy Division issued the following statement today after the Trump administration adopted a “Notice of Benefit and Payment Parameters for 2021” that allows health plans to block drug…

To help in the response to the coronavirus pandemic, the U.S. Patent and Trademark Office today launched a new online platform, called “Patents 4 Partnerships,” to share patent information for various technologies to facilitate greater collaboration…

The Biotechnology Innovation Organization (BIO) is donating $10,000 to the Capital Area Food Bank to help the organization meet the increased demand for healthy and fresh food in the Washington, D.C. community due to the coronavirus outbreak. “As…

The Biotechnology Innovation Organization (BIO) announced today it will be moving the 2020 BIO International Convention scheduled for June 8-11 in San Diego to an online platform, in lieu of an in-person event for this year. The decision was based…

The Biotechnology Innovation Organization (BIO) this week hosted a productive virtual summit intended to foster collaboration among key government agencies and biopharmaceutical innovators with one goal: eradicating Covid-19. The two-day virtual…

Companies are Coming Together to Achieve Shared Goal of Eradicating the Virus  Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) underscored the industry’s commitment…

Maine is speeding up its transformation to a 21st-century, biobased economy with the passing of the Renewable Chemicals Tax Credit, which will foster the production of environmentally friendly innovations—like renewable chemicals and biobased…

BIO-Led Summit to Build Collaboration Between Biopharma Industry, Government Leaders & Scientific Experts  Responding to the rapidly evolving COVID-19 public health crisis, the Biotechnology Innovation Organization (BIO) is taking the…

The Securities and Exchange Commission (SEC) has adopted regulatory changes to provide small public companies with a temporary exemption from Sarbanes-Oxley 404(b) compliance. 404(b) requires public companies to report on the internal controls they…

Washington, D.C. (March 6, 2020) – The following statement can be attributed to Dana O’Brien, BIO’s Executive Vice President for Food & Agriculture urging USDA to establish a pre-market notification process within its plant biotechnology…